Granules India Ltd. benchmarking: Performance to industry peers

Financial

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Operational Metrics
Pharmaceuticals
Manufacturing Capacity - Paracetamol	34560.0 MTPA	n/a	10800.0 MTPA
Number of ANDA's Approved By USFDA	71.0 .	n/a	n/a
Manufacturing Capacity - Metformin	2000.0 MTPA	n/a	7200.0 MTPA
Number of ANDA's Filed in USA	91.0 .	n/a	n/a
Manufacturing Capacity - Ibuprofen	4800.0 MTPA	5000.0 MTPA	12000.0 MTPA
US DMF Filings	47.0 .	230.0 .	n/a
Europe DMF Filings	11.0 .	n/a	n/a
Total reactor capacity	626.5 kL	n/a	n/a
Number of ANDA's Filed	148.0 .	n/a	n/a
Number of ANDA's Approved	97.0 .	n/a	n/a
R&D as a % of Total Sales	5.3 %	n/a	1.01 %
Financials
5 yr Average ROE	14.39 %	2.8 %	8.9 %
5yr average Equity Multiplier	1.67	1.99	1.42
5yr Average Asset Turnover Ratio	0.8	0.54	0.99
5yr Avg Net Profit Margin	10.74 %	-7.28 %	6.28 %
Price to Book	4.4	2.22	2.68
P/E	37.61	0.0	35.0
5yr Avg Cash Conversion Cycle	-47.47 Days	28.67 Days	37.81 Days
Inventory Days	71.87 Days	111.94 Days	65.55 Days
Days Receivable	33.72 Days	95.97 Days	86.45 Days
Days Payable	131.42 Days	146.85 Days	100.1 Days
5yr Average Interest Coverage Ratio	11.95	0.25	15.8
5yr Avg ROCE	19.47 %	2.1 %	12.63 %
5yr Avg Operating Profit Margin	20.32 %	9.63 %	10.64 %
5 yr average Debt to Equity	0.36	0.7	0.04
5yr CAGR Net Profit	7.59 %	-69.98 %	-9.63 %
5yr Average Return on Assets	8.59 %	-3.67 %	6.27 %
Shareholdings
Promoter Holding	38.02 %	42.0 %	62.28 %
Share Pledged by Promoters	0.0	31.57 %	0.0
Change in Promoter Holding (3 Yrs)	-4.0 %	1.03 %	14.09 %
Change in Mutual Fund Holding (3 Yrs)	-1.42 %	-1.03 %	0.0

Business

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Paracetamol 46.0 Metformin 22.0 Ibuprofen 10.0 GGF 4.0 MCB 3.0 Ibuprofen 0 Active Pharmaceutical Ingredients (API) 0 API 0 Chemicals 0 Ethyl Acetate 0 Pantaprazole 0 Clopidogrel 0 Metformin 0 Others 15.0	Product Wise Break-Up Metformin 0 Active Pharmaceutical Ingredient (API) 100.0 Paracetamol 0 Pantaprazole 0 MCB 0 Ethyl Acetate 0 API 0 Clopidogrel 0 GGF 0 Ibuprofen 0 Chemicals 0	Product Wise Break-Up Metformin 0 Active Pharmaceutical Ingredients (API) 0 Paracetamol 0 Pantaprazole 0 MCB 0 Ethyl Acetate 0 API 20.0 Clopidogrel 0 GGF 0 Ibuprofen 37.0 Chemicals 43.0
Segment Break-Up	Segment Break-Up Formulations 73.0 Active Pharmaceutical Ingredient (API) 13.0 PFI 9.0 Peptide/CDMO 5.0 0 Pharmaceuticals 0	-	Segment Break-Up Active Pharmaceutical Ingredient (API) 0 PFI 0 Pharmaceutical 54.85 Formulations 0 Chemicals 44.88 Peptide/CDMO 0 Others 0.27
Location Wise Break-Up	Location Wise Break-Up USA 72.0 Europe 17.0 Rest of the World 11.0 Canada 0 AMEA 0 Latin America 0 India 0 South America 0 North America 0 Asia Pacific 0	Location Wise Break-Up North America 5.85 South America 4.66 AMEA 0 Rest of the World 0 Asia Pacific 65.31 Canada 0 India 0 Latin America 0 Europe 20.24 USA 0 Others 3.94	Location Wise Break-Up North America 0 South America 0 AMEA 0 Rest of the World 24.0 Asia Pacific 0 Canada 0 India 76.0 Latin America 0 Europe 0 USA 0

Granules India Ltd.

Granules India Ltd.

Financial

Business

SIGN UP FOR FREE